Bristol-Myers Squibb Company (BMY) Stock buybacks 2016–2025
Bristol-Myers Squibb Company (BMY) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$0FY2025 · since FY2016: $231.0M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | — |
| FY2024 | $0 | -100.0% |
| FY2023 | $5.2B | -35.6% |
| FY2022 | $8.0B | +27.3% |
| FY2021 | $6.3B | +306.7% |
| FY2020 | $1.5B | -78.8% |
| FY2019 | $7.3B | +2181.3% |
| FY2018 | $320.0M | -87.0% |
| FY2017 | $2.5B | +968.8% |
| FY2016 | $231.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice